NYSE
(
- photonic integrated circuit based optoelectronic modules/subsystems for high-speed comm. networks, closes $7.25/sh. follow-on offering
(
- owns a fleet of 32 double-hull and other vessels, $80M equity dist. agr.; highest Q1 crude tanker/LR2 spot rates in years, FCF +31% vs. Q4
(
- nation's leading lifestyle retailer of western and work-related footwear, apparel and accessories, agreement to acquire 116-year old Sheplers
NYSE MKT AMEX
(
- develops targeted anti-infective drugs, data validates antibiotic platform expansion; expands team; hosts microbiome analyst/investor meet
NASDAQ
(
- biotech focused on synthetic cancer vaccines, presents positive ONT-380 data in HER2-positive breast cancer at ASCO, updates dev. plan
(
- FDA clears new drug app. for phase 2 study of ADXS-HPV and (
(
- proprietary Biochronomer drug delivery technology, positive top-line results from its new cancer therapy phase 3 MAGIC study
(
- precision oncology biotech with an Rx/Dx strategy to treat cancer, phase 1 clinical trial data for Entrectinib; CFO presents at healthcare conf.
TSX Venture (quote V. and ticker symbol)
(
- gold producer with 4-Quebec and 1-Ontario properties, updates net earning at Bachelor mine as cash cost drops to $US 849 per ounce
(
- produces wireless connectivity solutions, high precision frequency control devices, timing devices, and microwave filters, strong Q1 results
(
- exploring for industrial and other minerals in sw-Quebec, bolsters management team; takes key steps towards commercial operations
(
- edu-tech for online learning, training and social media for teachers, students, professionals, Q1 net profit +294.3%; 2014 revenue $10M+
Sign-up at InvestorsGuru.com (or blog.InvestorsGuru.com) for our Small Cap Stock Observer newsletter, and to set-up your own My Portfolio, My Watchlist & Alerts and News by Email preferences, or quote to comment at our AnyTicker.com Bulletin Boards. Free!
No comments:
Post a Comment